John Neis is the Managing Director at Venture Investors in Madison, Wisconsin. See sector focus and contact routes.
John Neis is the Managing Director at Venture Investors in Madison, Wisconsin, where he joined in May 1985 and served as Executive Managing Director from 2000 to 2021 before continuing as a Partner. His firm focuses exclusively on healthcare opportunities, particularly those spinning out of university ecosystems in the Midwest, and is the only venture capital firm in the region that funds therapeutic development. Venture Investors makes seed and early-stage technology investments in healthcare and technology companies across the midwestern United States. Neis serves on the boards of portfolio companies including Cellectar BioSciences, Delphinus Medical Technologies, PrevaCept Infection Control, and TAI Diagnostics. He has achieved successful exits with companies such as Third Wave, TomoTherapy, and Nimblegen. Neis is also an influential voice on entrepreneurial public policy through his long-standing volunteer service on the Wisconsin Technology Council. While his specific check size and lead/follow behavior are not publicly detailed, his firm’s focus on early-stage university spinouts defines his investment approach.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Madison when building a target list.
Investors like John Neis · Full investor directory · Investor access · Company funding database